![logo](/logos/GKOS.webp)
Glaukos Corporation
NYSE:GKOS
129.28 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Glaukos Corporation |
Symbool | GKOS |
Munteenheid | USD |
Prijs | 129.28 |
Beurswaarde | 7,104,000,640 |
Dividendpercentage | 0% |
52-weken bereik | 59.22 - 136.605 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Thomas William Burns |
Website | https://www.glaukos.com |
An error occurred while fetching data.
Over Glaukos Corporation
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma.
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)